AMANDA GONNELLA: Open Payments
NPI 1740959279 · CULPEPER, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$236 in 11 payments from 9 companies in 2025. Trend: 2023 $42 · 2024 $182 · 2025 $236
Food & beverage: $236
| Company | Payments | Amount |
|---|---|---|
| IBSA Pharma Inc. | 2 | $42 |
| Novo Nordisk Inc | 2 | $36 |
| ALK-Abello, Inc | 1 | $28 |
| Lilly USA, LLC | 1 | $24 |
| Sumitomo Pharma America, Inc. | 1 | $24 |
| ABBVIE INC. | 1 | $22 |
| Abbott Laboratories | 1 | $22 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $21 |
| PFIZER INC. | 1 | $16 |
Products named: Tirosint, Ozempic, NEFFY, MOUNJARO, GEMTESA, UBRELVY, FREESTYLE LIBRE 3, JOURNAVX.
Industry payments across VA — which companies pay providers there.
